Christopher R. D’Angelo, MD

Christopher R. D’Angelo, MD, discusses factors that determine whether CAR T-cell therapy or autologous stem cell transplant should be used in patients with relapsed/refractory diffuse large B-cell lymphoma.

Christopher R. D’Angelo, MD, discusses advances made with CAR T-cell therapy in lymphoma.